CDNA Logo

CareDx Inc (CDNA) Stock Forecast & Price Prediction

Live CDNA Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NASDAQ | Healthcare | Diagnostics & Research

$24.50

-0.34 (-1.37%)

12 Month Price Forecast For CDNA

$24.50
Current Price
$1.31B
Market Cap
8 Ratings
Buy 5
Hold 3
Sell 0
Wall St Analyst Ratings

Distance to CDNA Price Forecasts

+63.3%
To High Target of $40.00
+42.9%
To Median Target of $35.00
-2.0%
To Low Target of $24.00

CDNA Price Momentum

+9.3%
1 Week Change
+7.9%
1 Month Change
+188.2%
1 Year Change
+14.4%
Year-to-Date Change
-29.7%
From 52W High of $34.84
+230.2%
From 52W Low of $7.42

๐Ÿค” Considering CareDx (CDNA)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 15, 2025 12:11 PM UTC

CDNA Analyst Ratings & Price Targets

Based on our analysis of 12 Wall Street analysts, CDNA has a bullish consensus with a median price target of $35.00 (ranging from $24.00 to $40.00). Currently trading at $24.50, the median forecast implies a 42.9% upside. This outlook is supported by 5 Buy, 3 Hold, and 0 Sell ratings.

The most optimistic forecast comes from Sung Ji Nam at BTIG, projecting a 63.3% upside. Conversely, the most conservative target is provided by Brandon Couillard at Wells Fargo, suggesting a 2.0% downside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

CDNA Analyst Consensus

5
Buy
3
Hold
0
Sell

CDNA Price Target Range

Low
$24.00
Average
$35.00
High
$40.00
Current: $24.50

Latest CDNA Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for CDNA.

Date Firm Analyst Rating Change Price Target
Jan 15, 2025 Wells Fargo Brandon Couillard Equal-Weight Upgrade $24.00
Jan 14, 2025 HC Wainwright & Co. Yi Chen Neutral Reiterates $26.00
Nov 5, 2024 BTIG Sung Ji Nam Buy Maintains $35.00
Oct 22, 2024 HC Wainwright & Co. Yi Chen Neutral Reiterates $0.00
Oct 16, 2024 Goldman Sachs Matthew Sykes Buy Maintains $35.00
Aug 27, 2024 Wells Fargo Brandon Couillard Underweight Initiates $28.00
Aug 19, 2024 BTIG Sung Ji Nam Buy Upgrade $40.00
Aug 1, 2024 Craig-Hallum Connor Chamberlain Buy Maintains $32.00
Aug 1, 2024 HC Wainwright & Co. Yi Chen Neutral Reiterates $0.00
Aug 1, 2024 Goldman Sachs Matthew Sykes Buy Maintains $26.00
Jul 17, 2024 Goldman Sachs Matthew Sykes Buy Maintains $16.00
May 31, 2024 HC Wainwright & Co. Yi Chen Neutral Reiterates $0.00
May 17, 2024 Craig-Hallum Connor Chamberlain Buy Maintains $22.00
May 15, 2024 HC Wainwright & Co. Yi Chen Neutral Reiterates $0.00
May 13, 2024 Raymond James Andrew Cooper Market Perform Downgrade $0.00
May 13, 2024 Goldman Sachs Matthew Sykes Buy Maintains $14.00
May 13, 2024 Stephens & Co. Mason Carrico Overweight Maintains $18.00
May 9, 2024 Craig-Hallum Connor Chamberlain Buy Reiterates $15.00
May 1, 2024 Craig-Hallum Alexander Nowak Buy Upgrade $15.00
Apr 17, 2024 Stephens & Co. Mason Carrico Overweight Reiterates $15.00

Stocks Similar to CareDx Inc

The following stocks are similar to CareDx based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

CareDx Inc (CDNA) Financial Data

CareDx Inc has a market capitalization of $1.31B with a P/E ratio of -6.9x. The company generates $312.78M in trailing twelve-month revenue with a -45.9% profit margin.

Revenue growth is +23.4% quarter-over-quarter, while maintaining an operating margin of -12.7% and return on equity of -43.0%.

Valuation Metrics

Market Cap $1.31B
Enterprise Value $1.10B
P/E Ratio -6.9x
PEG Ratio 42.2x
Price/Sales 4.2x

Growth & Margins

Revenue Growth (YoY) +23.4%
Gross Margin +66.7%
Operating Margin -12.7%
Net Margin -45.9%
EPS Growth +23.4%

Financial Health

Cash/Price Ratio +18.3%
Current Ratio 4.1x
Debt/Equity 11.0x
ROE -43.0%
ROA -7.5%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

CareDx Inc logo

CareDx Inc (CDNA) Company Overview

About CareDx Inc

What They Do

Develops diagnostic solutions for transplant patients.

Business Model

The company generates revenue by offering a range of diagnostic products and services specifically designed for transplant patients and their caregivers. This includes proprietary solutions like AlloSure and AlloMap, which utilize advanced technologies such as donor-derived cell-free DNA analysis and gene expression profiling. CareDx sells its products directly to customers and through third-party distributors, enhancing its market reach.

Additional Information

CareDx has established significant partnerships, including a license agreement with Illumina, Inc. for next-generation sequencing products. Additionally, the company provides a variety of software solutions for transplant management and patient care, indicating a comprehensive approach to supporting transplant recipients. Founded in 1998 and headquartered in South San Francisco, California, CareDx has a strong focus on innovation in the transplant diagnostics market.

Company Information

Sector

Healthcare

Industry

Diagnostics & Research

Employees

635

CEO

Mr. John Walter Hanna Jr.

Country

United States

IPO Year

2014

Website

caredx.com

CareDx Inc (CDNA) Latest News & Analysis

CDNA stock latest news image
Quick Summary

CareDx, Inc. (Nasdaq: CDNA) will report its Q4 and full-year 2024 financial results on February 26, 2025, after market close, with a conference call at 1:30 PM PT.

Why It Matters

CareDx's upcoming financial report could reveal key performance metrics and future outlook, influencing investor sentiment and stock price movements.

Source: Business Wire
Market Sentiment: Neutral
CDNA stock latest news image
Quick Summary

CareDx (CDNA) experienced significant trading volume recently, with trends in earnings estimate revisions potentially supporting further stock price increases.

Why It Matters

Higher trading volume and positive earnings estimate revisions suggest increased investor interest and potential for further stock price appreciation in CareDx.

Source: Zacks Investment Research
Market Sentiment: Positive
CDNA stock latest news image
Quick Summary

The Investment Committee has identified key stocks to monitor for the second half of the year.

Why It Matters

The recommendation of top stocks signals potential growth opportunities, impacting investment strategies and portfolio adjustments for the second half of the year.

Source: CNBC Television
Market Sentiment: Positive
CDNA stock latest news image
Quick Summary

CareDx (CDNA) has a consensus price target suggesting a 42.3% upside potential, supported by an upward trend in earnings estimate revisions.

Why It Matters

A 42.3% upside potential indicates significant growth potential for CareDx (CDNA), while rising earnings estimates suggest positive momentum, attracting investor interest.

Source: Zacks Investment Research
Market Sentiment: Positive
CDNA stock latest news image
Quick Summary

On January 30, 2024, BBCP, SDVKY, OBK, CDNA, and NVAX were added to the Zacks Rank #1 (Strong Buy) List.

Why It Matters

Stocks on the Zacks Rank #1 list indicate strong potential for price appreciation, suggesting favorable investment opportunities for potential gains.

Source: Zacks Investment Research
Market Sentiment: Positive
CDNA stock latest news image
Quick Summary

OBK, BBCP, and CDNA are rated as Zacks Rank #1 (Strong Buy) momentum stocks as of January 30, 2024.

Why It Matters

The inclusion of OBK, BBCP, and CDNA in the Zacks Rank #1 list signals strong growth potential, attracting investor interest and potentially driving stock prices higher.

Source: Zacks Investment Research
Market Sentiment: Positive

Frequently Asked Questions About CDNA Stock

What is CareDx Inc's (CDNA) stock forecast for 2025?

Based on our analysis of 12 Wall Street analysts, CareDx Inc (CDNA) has a median price target of $35.00. The highest price target is $40.00 and the lowest is $24.00.

Is CDNA stock a good investment in 2025?

According to current analyst ratings, CDNA has 5 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $24.50. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for CDNA stock?

Wall Street analysts predict CDNA stock could reach $35.00 in the next 12 months. This represents a 42.9% increase from the current price of $24.50. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is CareDx Inc's business model?

The company generates revenue by offering a range of diagnostic products and services specifically designed for transplant patients and their caregivers. This includes proprietary solutions like AlloSure and AlloMap, which utilize advanced technologies such as donor-derived cell-free DNA analysis and gene expression profiling. CareDx sells its products directly to customers and through third-party distributors, enhancing its market reach.

What is the highest forecasted price for CDNA CareDx Inc?

The highest price target for CDNA is $40.00 from Sung Ji Nam at BTIG, which represents a 63.3% increase from the current price of $24.50.

What is the lowest forecasted price for CDNA CareDx Inc?

The lowest price target for CDNA is $24.00 from Brandon Couillard at Wells Fargo, which represents a -2.0% decrease from the current price of $24.50.

What is the overall CDNA consensus from analysts for CareDx Inc?

The overall analyst consensus for CDNA is bullish. Out of 12 Wall Street analysts, 5 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $35.00.

How accurate are CDNA stock price projections?

Stock price projections, including those for CareDx Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.